SCHEMBL7004985

SCHEMBL7004985

C[C@H]1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2cc(N)c(F)cc2F)C[C@@H]1N

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.48
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
ALDH1A1 P00352 7/20 0.46
KDM4E B2RXH2 6/20 0.46
HSD17B10 Q99714 5/20 0.46
HPGD P15428 5/20 0.46
DRD3 P35462 1/20 0.44
MAPT P10636 1/20 0.44
CYP2C9 P11712 2/20 0.43
CYP1A2 P05177 1/20 0.43
TOP2A P11388 1/20 0.43
TOP2B Q02880 1/20 0.43
BRD4 O60885 1/20 0.43
TSHR P16473 1/20 0.43
HTT P42858 1/20 0.43
CYP2J2 P51589 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TOP1 P11387 2/20 0.42
GSK3B P49841 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7004999 1.00 LMNA (0.48) LMNAKMT2AMEN1ALDH1A1KDM4E
SCHEMBL7004991 1.00 LMNA (0.48) LMNAKMT2AMEN1ALDH1A1KDM4E
SCHEMBL7009468 1.00 LMNA (0.48) LMNAKMT2AMEN1ALDH1A1KDM4E
SCHEMBL7009980 0.91 LMNA (0.48) LMNAKMT2AMEN1ALDH1A1KDM4E
SCHEMBL7009970 0.91 LMNA (0.48) LMNAKMT2AMEN1ALDH1A1KDM4E
SCHEMBL7009977 0.91 LMNA (0.48) LMNAKMT2AMEN1ALDH1A1KDM4E
SCHEMBL7013177 0.89 LMNA (0.50) LMNAKMT2AMEN1ALDH1A1KDM4E
SCHEMBL8484857 0.88 LMNA (0.49) LMNAKMT2AMEN1ALDH1A1KDM4E
SCHEMBL10665291 0.87 EPHA2 (0.56) LMNAKMT2AMEN1ALDH1A1KDM4E
SCHEMBL10663315 0.85 LMNA (0.68) LMNAKMT2AMEN1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0787720-B1 PYRIDONECARBOXYLATE DERIVATIVE OR SALT THEREOF AND ANTIBACTERIAL CONTAINING THE SAME AS ACTIVE INGREDIENT WAKUNAGA SEIYAKU KK (JP) 2003-07-16 EP disclosed
US-5910498-A NOVEL COMPOUNDS HAVING REDUCED CYTOTOXICITY, PHOTOTOXICITY; TREATING BACTERIAL AND VIRAL INFECTIONS WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) 1999-06-08 US disclosed
EP-0787720-A1 NOVEL PYRIDONECARBOXYLATE DERIVATIVE OR SALT THEREOF AND ANTIBACTERIAL CONTAINING THE SAME AS ACTIVE INGREDIENT WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) 1997-08-06 EP disclosed